Since the beginning of February 2018, we have tested a number of substances of particular health concern. In a sample submitted for analysis as an ecstasy tablet, the new psychoactive substance 2C-P (2,5-dimethoxy-4-propylphenethylamine) identified. Instead of the expected active ingredient, a supposed MDMA sample showed the new psychoactive substance Clephedrone (4-CMC) from the cathinone group.

Current warnings February 2018